Marco Boeri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

The patient

PharmacoEconomics

The Journal of dermatological treatment

Current medical research and opinion

RTI International

Queen's University Belfast (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RTI International Feb 01 2016

United States

Senior Research Economist :: Health preference assessment

Education History

Queen's University Belfast Dec 13 2011

United Kingdom

PHD

Publications

Caroline M Vass, Marco Boeri, Gemma Elizabeth Shields, Jaein Seo
Making Use of Technology to Improve Stated Preference Studies. The patient 17 (5) (2024)
Caroline M Vass, Marco Boeri, Gemma Elizabeth Shields, Jaein Seo
Making Use of Technology to Improve Stated Preference Studies. The patient (2024)
Steven R Feldman, Jacob P Thyssen, Marco Boeri, Robert Gerber, Maureen P Neary, Amy Cha, Brett Hauber, Joseph C Cappelleri, Jason Xenakis, Colton Leach, Joshua Zeichner
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment. The Journal of dermatological treatment 35 (1) (2024)
Salome Samant, Susanne Oberle, Tomáš Marček, Christine Poulos, Phani Chintakayala, Edith Langevin, Tanaz Petigara, Marco Boeri
Preferences of healthcare providers in Switzerland for attributes of pediatric hexavalent vaccines: a discrete-choice experiment. Current medical research and opinion 40 (5) (2024)
Salome Samant, Susanne Oberle, Tomáš Marček, Christine Poulos, Phani Chintakayala, Edith Langevin, Tanaz Petigara, Marco Boeri
Preferences of healthcare providers in Switzerland for attributes of pediatric hexavalent vaccines: a discrete-choice experiment. Current medical research and opinion 40 (5) (2024)
Steven R Feldman, Jacob P Thyssen, Marco Boeri, Robert Gerber, Maureen P Neary, Amy Cha, Brett Hauber, Joseph C Cappelleri, Jason Xenakis, Colton Leach, Joshua Zeichner
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment. The Journal of dermatological treatment 35 (1) (2024)
Caroline M Vass, Marco Boeri, Gemma Elizabeth Shields, Jaein Seo
Making Use of Technology to Improve Stated Preference Studies. The patient 17 (5) (2024)
Salome Samant, Susanne Oberle, Tomáš Marček, Christine Poulos, Phani Chintakayala, Edith Langevin, Tanaz Petigara, Marco Boeri
Preferences of healthcare providers in Switzerland for attributes of pediatric hexavalent vaccines: a discrete-choice experiment. Current medical research and opinion (2024)
Marco Boeri, Maral K Skelsey, James A Schiro, Susan E Dozier, Robert Glinert, Martin M Okun
Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer. The Journal of dermatological treatment 34 (1) (2023)
Marco Boeri, A Brett Hauber, Joseph Christopher Cappelleri
Considerations Around Coding the Membership Probability Function in a Latent Class Analysis: Renewed Insights. PharmacoEconomics 40 (7) (2022)
Juan Marcos Gonzalez, Marco Boeri
The Impact of the Risk Functional Form Assumptions on Maximum Acceptable Risk Measures. The patient 14 (6) (2021)
Marco Boeri, Daniel Saure, Alexander Schacht, Elisabeth Riedl, Brett Hauber
Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches. PharmacoEconomics 38 (6) (2021)
Maria Veronica Dorgali, Alberto Longo, Caroline M Vass, Gemma Elizabeth Shields, Roger Harrison, Riccardo Scarpa, Marco Boeri
A General Public Study on Preferences and Welfare Impacts of Antimicrobial Resistance in the United Kingdom. PharmacoEconomics (2021)
Marco Boeri, Anna G Purdum, Jessie Sutphin, A Brett Hauber, James A Kaye
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion. Future oncology (London, England) 17 (34) (2021)
Caroline M Vass, Marco Boeri
Mobilising the Next Generation of Stated-Preference Studies: the Association of Access Device with Choice Behaviour and Data Quality. The patient 14 (1) (2020)
Carol A Mansfield, Jessie Sutphin, Marco Boeri
Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health economics 29 (10) (2020)

Marco Boeri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Boeri